260 related articles for article (PubMed ID: 21705677)
1. Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.
Egom EE; Mohamed TM; Mamas MA; Shi Y; Liu W; Chirico D; Stringer SE; Ke Y; Shaheen M; Wang T; Chacko S; Wang X; Solaro RJ; Fath-Ordoubadi F; Cartwright EJ; Lei M
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1487-95. PubMed ID: 21705677
[TBL] [Abstract][Full Text] [Related]
2. FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling.
Egom EE; Ke Y; Musa H; Mohamed TM; Wang T; Cartwright E; Solaro RJ; Lei M
J Mol Cell Cardiol; 2010 Feb; 48(2):406-14. PubMed ID: 19852968
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.
Means CK; Xiao CY; Li Z; Zhang T; Omens JH; Ishii I; Chun J; Brown JH
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2944-51. PubMed ID: 17293497
[TBL] [Abstract][Full Text] [Related]
4. FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning.
Vessey DA; Li L; Imhof I; Honbo N; Karliner JS
Med Sci Monit Basic Res; 2013 Apr; 19():126-32. PubMed ID: 23567658
[TBL] [Abstract][Full Text] [Related]
5. Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart.
Liu W; Zi M; Naumann R; Ulm S; Jin J; Taglieri DM; Prehar S; Gui J; Tsui H; Xiao RP; Neyses L; Solaro RJ; Ke Y; Cartwright EJ; Lei M; Wang X
Circulation; 2011 Dec; 124(24):2702-15. PubMed ID: 22082674
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion.
Hofmann U; Hu K; Walter F; Burkard N; Ertl G; Bauersachs J; Ritter O; Frantz S; Bonz A
Br J Pharmacol; 2010 Jul; 160(5):1243-51. PubMed ID: 20590616
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.
Qin X; Yue Z; Sun B; Yang W; Xie J; Ni E; Feng Y; Mahmood R; Zhang Y; Yue L
Br J Pharmacol; 2013 Mar; 168(6):1294-312. PubMed ID: 23145923
[TBL] [Abstract][Full Text] [Related]
12. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes.
Karliner JS; Honbo N; Summers K; Gray MO; Goetzl EJ
J Mol Cell Cardiol; 2001 Sep; 33(9):1713-7. PubMed ID: 11549349
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine-1-Phosphate Improves the Biological Features of Mouse Bone Marrow-Derived EPCs Partially through PI3K/AKT/eNOS/NO Pathway.
Wang X; Zhan E; Lu G; Mu Q; Zhang T; Yang N
Molecules; 2019 Jun; 24(13):. PubMed ID: 31261859
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore.
Rana A; Sharma S
Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):166-73. PubMed ID: 26582369
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine 1-Phosphate Postconditioning Protects Against Myocardial Ischemia/reperfusion Injury in Rats via Mitochondrial Signaling and Akt-Gsk3β Phosphorylation.
Fang R; Zhang LL; Zhang LZ; Li W; Li M; Wen K
Arch Med Res; 2017 Feb; 48(2):147-155. PubMed ID: 28625317
[TBL] [Abstract][Full Text] [Related]
16. Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection.
Zhao X; Ding EY; Yu OM; Xiang SY; Tan-Sah VP; Yung BS; Hedgpeth J; Neubig RR; Lau LF; Brown JH; Miyamoto S
J Mol Cell Cardiol; 2014 Oct; 75():152-61. PubMed ID: 25106095
[TBL] [Abstract][Full Text] [Related]
17. Effect of sphingosine-1-phosphate on L-type calcium current and Ca(2+) transient in rat ventricular myocytes.
Egom EE; Bae JS; Capel R; Richards M; Ke Y; Pharithi RB; Maher V; Kruzliak P; Lei M
Mol Cell Biochem; 2016 Aug; 419(1-2):83-92. PubMed ID: 27372350
[TBL] [Abstract][Full Text] [Related]
18. Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3.
Kelly-Laubscher RF; King JC; Hacking D; Somers S; Hastie S; Stewart T; Imamdin A; Maarman G; Pedretti S; Lecour S
Cardiovasc J Afr; 2014; 25(3):118-23. PubMed ID: 25000441
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective role of sphingosine-1-phosphate.
Knapp M
J Physiol Pharmacol; 2011 Dec; 62(6):601-7. PubMed ID: 22314562
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.
Morel S; Christoffersen C; Axelsen LN; Montecucco F; Rochemont V; Frias MA; Mach F; James RW; Naus CC; Chanson M; Lampe PD; Nielsen MS; Nielsen LB; Kwak BR
Cardiovasc Res; 2016 Mar; 109(3):385-96. PubMed ID: 26762268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
